title: The evolving role of tor inhibitors for individualizing posttransplant immunosuppression.
authors.affiliation: Department of Surgery, Organ Transplantation & Immunology Section, Yale University School of Medicine, New Haven, CT 06520, USA.
authors.forename: M I
authors.initials: MI
authors.lastname: Lorber
authors.forename: G P
authors.initials: GP
authors.lastname: Basadonna
authors.forename: A L
authors.initials: AL
authors.lastname: Friedman
authors.forename: K M
authors.initials: KM
authors.lastname: Lorber
authors.forename: M J
authors.initials: MJ
authors.lastname: Bia
authors.forename: R
authors.initials: R
authors.lastname: Formica
authors.forename: J D
authors.initials: JD
authors.lastname: Smith
mesh_terms: D065095:Calcineurin Inhibitors; D000068338:Everolimus; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011499:Protein Processing, Post-Translational / Q000276:immunology*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D014181:Transplantation Immunology
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus